# Commission Regulation (EC) No 703/2007 of 21 June 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Dihydrostreptomycin and Streptomycin (Text with EEA relevance), Division 1.2.10

Extent: E+W+S+N.I.

Aminoglycosides
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target issues
‘Dihydrostreptomycin
Dihydrostreptomycin
All ruminants
500 μg/kg
Muscle
500 μg/kg
Fat
500 μg/kg
Liver
1 000 μg/kg
Kidney
200 μg/kg
Milk
Porcine
500 μg/kg
Muscle
500 μg/kg
Skin + fat
500 μg/kg
Liver
1 000 μg/kg
Kidney
Rabbits
500 μg/kg
Muscle
500 μg/kg
Fat
500 μg/kg
Liver
1 000 μg/kg
Kidney
Streptomycin
Streptomycin
All ruminants
500 μg/kg
Muscle
500 μg/kg
Fat
500 μg/kg
Liver
1 000 μg/kg
Kidney
200 μg/kg
Milk
Porcine
500 μg/kg
Muscle
500 μg/kg
Skin + fat
500 μg/kg
Liver
1 000 μg/kg
Kidney
Rabbits
500 μg/kg
Muscle
500 μg/kg
Fat
500 μg/kg
Liver
1 000 μg/kg
Kidney’

---
Source: https://www.legislation.gov.uk/eur/2007/703/annex/division/1/division/1.2/division/1.2.10 (the official version)
Page: https://openlegislation.uk/eu-regulation-2007-703/annex/division-1/division-1.2/division-1.2.10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.